Bausch Health Cos Net Profit Margin 2010-2023 | BHC
Bausch Health Cos net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Bausch Health Cos Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2023-12-31 |
$8.76B |
$-0.59B |
-6.76% |
| 2023-09-30 |
$8.54B |
$-0.96B |
-11.27% |
| 2023-06-30 |
$8.35B |
$-0.19B |
-2.23% |
| 2023-03-31 |
$8.15B |
$-0.36B |
-4.38% |
| 2022-12-31 |
$8.12B |
$-0.23B |
-2.77% |
| 2022-09-30 |
$8.13B |
$0.25B |
3.13% |
| 2022-06-30 |
$8.19B |
$0.04B |
0.52% |
| 2022-03-31 |
$8.33B |
$-0.41B |
-4.89% |
| 2021-12-31 |
$8.43B |
$-0.95B |
-11.24% |
| 2021-09-30 |
$8.45B |
$-1.17B |
-13.84% |
| 2021-06-30 |
$8.48B |
$-1.29B |
-15.18% |
| 2021-03-31 |
$8.04B |
$-1.02B |
-12.66% |
| 2020-12-31 |
$8.03B |
$-0.56B |
-6.98% |
| 2020-09-30 |
$8.04B |
$-1.92B |
-23.92% |
| 2020-06-30 |
$8.11B |
$-2.04B |
-25.19% |
| 2020-03-31 |
$8.60B |
$-1.89B |
-21.96% |
| 2019-12-31 |
$8.60B |
$-1.79B |
-20.79% |
| 2019-09-30 |
$8.50B |
$-0.62B |
-7.25% |
| 2019-06-30 |
$8.43B |
$-0.92B |
-10.88% |
| 2019-03-31 |
$8.40B |
$-1.62B |
-19.27% |
| 2018-12-31 |
$8.38B |
$-4.15B |
-49.50% |
| 2018-09-30 |
$8.42B |
$-3.29B |
-39.08% |
| 2018-06-30 |
$8.51B |
$-1.64B |
-19.28% |
| 2018-03-31 |
$8.61B |
$-0.81B |
-9.35% |
| 2017-12-31 |
$8.72B |
$2.40B |
27.56% |
| 2017-09-30 |
$8.96B |
$1.38B |
15.35% |
| 2017-06-30 |
$9.22B |
$-1.14B |
-12.39% |
| 2017-03-31 |
$9.41B |
$-1.41B |
-14.95% |
| 2016-12-31 |
$9.67B |
$-2.41B |
-24.90% |
| 2016-09-30 |
$10.03B |
$-2.28B |
-22.73% |
| 2016-06-30 |
$10.34B |
$-1.01B |
-9.79% |
| 2016-03-31 |
$10.65B |
$-0.76B |
-7.16% |
| 2015-12-31 |
$10.45B |
$-0.29B |
-2.79% |
| 2015-09-30 |
$9.91B |
$0.60B |
6.02% |
| 2015-06-30 |
$9.18B |
$0.82B |
8.95% |
| 2015-03-31 |
$8.49B |
$1.00B |
11.79% |
| 2014-12-31 |
$8.21B |
$0.88B |
10.72% |
| 2014-09-30 |
$8.05B |
$0.50B |
6.24% |
| 2014-06-30 |
$7.53B |
$-0.75B |
-9.90% |
| 2014-03-31 |
$6.59B |
$-0.86B |
-13.07% |
| 2013-12-31 |
$5.77B |
$-0.87B |
-15.01% |
| 2013-09-30 |
$4.63B |
$-1.08B |
-23.32% |
| 2013-06-30 |
$3.97B |
$-0.10B |
-2.47% |
| 2013-03-31 |
$3.69B |
$-0.13B |
-3.55% |
| 2012-12-31 |
$3.48B |
$-0.12B |
-3.33% |
| 2012-09-30 |
$3.21B |
$0.03B |
0.90% |
| 2012-06-30 |
$2.93B |
$0.06B |
2.12% |
| 2012-03-31 |
$2.72B |
$0.14B |
5.15% |
| 2011-12-31 |
$2.43B |
$0.16B |
6.55% |
| 2011-09-30 |
$2.29B |
$0.07B |
3.14% |
| 2011-06-30 |
$1.90B |
$-0.18B |
-9.33% |
| 2011-03-31 |
$1.53B |
$-0.20B |
-13.03% |
| 2010-12-31 |
$1.18B |
$-0.21B |
-17.60% |
| 2010-09-30 |
$0.91B |
$-0.10B |
-11.45% |
| 2010-06-30 |
$0.91B |
$0.14B |
15.77% |
| 2010-03-31 |
$0.87B |
$0.13B |
15.44% |
| 2009-12-31 |
$0.82B |
$0.18B |
21.44% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.088B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
